http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
아토피피부염 환자에서 국소 tacrolimus 0.1%에 대한 약물정보지 제공의 효과 및 국소 tacrolimus 0.1% 효능과 환자의 순응도 평가
한지수 ( Ji Su Han ),이우진 ( Woo Jin Lee ),고주연 ( Joo Yeon Ko ),김정수 ( Joung Soo Kim ),김상석 ( Sang Seok Kim ),서수홍 ( Soo Hong Seo ),유박린 ( Bark Lynn Lew ),이가영 ( Ga Young Lee ),이주희 ( Ju Hee Lee ),박창욱 ( Chang Ook 대한천식알레르기학회 2013 Allergy Asthma & Respiratory Disease Vol.1 No.3
Purpose: Topical calcineurin inhibitor is recently developed topical immunomodulator, and preliminary studies showed its effectiveness in the treatment of atopic dermatitis (AD). However, some side effects including transient irritation can influence the patient compliance. So, there are some needs to improve the patient compliance. The purpose of this study was to evaluate the efficacy, safety and patient compliance with using topical tacrolimus 0.1% to treat AD when the correct information about topical tacrolimus are properly given to patients. Methods: We examined the medical recordings, clinical severity scoring of total 194 AD patients at 9 general hospitals in Seoul, Korea from September 2010 to August 2011. We offered an infosheet of topical tacrolimus 0.1% and the patients applied it twice a day for 2 weeks. And we measured the efficacy of the topical tacrolimus 0.1% with SCORing atopic dermatitis (SCORAD) index, patient`s global assessment (PGA), and investigator`s global assessment (IGA). Results: Topical tacrolimus 0.1% effectively controlled AD with a reduction of the SCORAD index from baseline 31.9 to 20.2 at 2 weeks of application. In IGA results showed 98% got improvement and in PGA, results showed 96% got improvement after treatment. Although 42.3% of the patients complained of adverse effects, these were all transient. The effect of information on topical tacrolimus 0.1% showed 34% patients could predict the side effect, 35% patients could feel safety to use, and 18% patients experienced side effect but could maintain topical calcineurin inhibitor. Conclusion: Topical tacrolimus 0.1% may be an effective treatment modality for AD when patients show good compliance for applying the ointment. And properly given, the correct information may increase the patient compliance. (Allergy Asthma Respir Dis 2013;1:221-226)
Isotretinoin와 Pulsed Dye Laser로 치료한 Rosai-Dorfman병
한지수 ( Ji Su Han ),김정은 ( Jeong Eun Kim ),박경훈 ( Gyeong Hoon Park ),원종현 ( Chong Hyun Won ),장성은 ( Sung Eun Chang ),이미우 ( Mi Woo Lee ),최지호 ( Jee Ho Choi ),문기찬 ( Kee Chan Moon ) 대한피부과학회 2013 대한피부과학회지 Vol.51 No.6
Rosai-Dorfman disease (RDD) or sinus histiocytosis with massive lymphadenopathy (SMHL) is a benign histiocytic proliferative disorder of unknown etiology. The disease is usually accompanied by massive bilateral lymphadenopathy, fever, elevated erythrocyte sedimentation rate, leukocytosis with neutrophilia, and polyclonal hypergammaglobulinemia. Histopathologic examinations showed characteristically large histiocytes exhibiting emperipolesis. On immunohistochemical stains, histiocytes are positive for CD68 and S-100 protein, but negative for CD1a. The lymph node involvement is typical, but it may also involve other systemic organs in one third of the cases such as skin, upper respiratory tract, bones and so on. Patients with purely cutaneous Rosai-Dorfman diseases are of older age at onset of the disease with a reversed male/female ratio, thus, cutaneous Rosai-Dorfman disease is recognized as a distinct entity from the Rosai-Dorfman disease. Herein, we present a 50-year-old man with erythematous papules and indurated plaques on both cheeks, diagnosed as cutaneous Rosai-Dorfman disease. The lesions were treated with isotretinoin 10 mg bid for 9 months with pulsed dye laser.
곡선형 형상적응형 냉각채널을 갖는 금형 코어 제작을 위한 DMT 공정개발
한지수(Ji Su Han),유만준(Man Jun Yu),이민규(Min Gyu Lee),이윤선(Yoon Sun Lee),김우성(Woo-Sung Kim),이호진(Ho Jin Lee),김다혜(Da Hye Kim),성지현(Ji Hyun Sung),차경제(Kyoung Je Cha) 한국기계가공학회 2019 한국기계가공학회지 Vol.18 No.11
The cooling rate and the uniformity of mold temperature, in the injection molding process, possess great influences on the productivity and quality of replications. The conformal cooling channel, which is of a uniform spacing from the mold cavity by the metal additive manufacturing process, receives much attention recently. The purpose of this study is to develop a mold core with a curved conformal cooling channel for a pottery-shaped thick-wall cosmetic container through the hybrid method of direct metal tooling (DMT) process. In this study, we design a mold core that contains the curved cooling channel for the container. A method that divides the cavity is proposed and the DMT process is carried out to form the curved cooling channel. The test mold core, with the curved conformal cooling channel, has been fabricated by the proposed method to confirm the feasibility of the design concept. We show that no leakage is observed for the additive manufactured test mold core, and its physical properties demonstrate that it can be sufficiently used as the injection mold core.
아토피피부염 환자에서 국소 tacrolimus 0.1%에 대한 약물정보지 제공의 효과 및 국소 tacrolimus 0.1% 효능과 환자의 순응도 평가
한지수 ( Ji Su Han ),이우진 ( Woo Jin Lee ),고주연 ( Joo Yeon Ko ),김정수 ( Joung Soo Kim ),김상석 ( Sang Seok Kim ),서수홍 ( Soo Hong Seo ),유박린 ( Bark Lynn Lew ),이가영 ( Ga Young Lee ),이주희 ( Ju Hee Lee ),박창욱 ( Chang Ook 대한소아알레르기호흡기학회 1991 소아알레르기 및 호흡기학회지 Vol.1 No.3
Purpose: Topical calcineurin inhibitor is recently developed topical immunomodulator, and preliminary studies showed its effectiveness in the treatment of atopic dermatitis (AD). However, some side effects including transient irritation can influence the patient compliance. So, there are some needs to improve the patient compliance. The purpose of this study was to evaluate the efficacy, safety and patient compliance with using topical tacrolimus 0.1% to treat AD when the correct information about topical tacrolimus are properly given to patients. Methods: We examined the medical recordings, clinical severity scoring of total 194 AD patients at 9 general hospitals in Seoul, Korea from September 2010 to August 2011. We offered an infosheet of topical tacrolimus 0.1% and the patients applied it twice a day for 2 weeks. And we measured the efficacy of the topical tacrolimus 0.1% with SCORing atopic dermatitis (SCORAD) index, patient’s global assessment (PGA), and investigator’s global assessment (IGA). Results: Topical tacrolimus 0.1% effectively controlled AD with a reduction of the SCORAD index from baseline 31.9 to 20.2 at 2 weeks of application. In IGA results showed 98% got improvement and in PGA, results showed 96% got improvement after treatment. Although 42.3% of the patients complained of adverse effects, these were all transient. The effect of information on topical tacrolimus 0.1% showed 34% patients could predict the side effect, 35% patients could feel safety to use, and 18% patients experienced side effect but could maintain topical calcineurin inhibitor. Conclusion: Topical tacrolimus 0.1% may be an effective treatment modality for AD when patients show good compliance for applying the ointment. And properly given, the correct information may increase the patient compliance. (Allergy Asthma Respir Dis 2013;1:221-226)
컴퓨터 교과 교육 2 : 프로그래밍 교육을 위한 동기유발 요인 설계 및 분석
한지수 ( Ji Su Han ),김철민 ( Chul Min Kim ),박찬정 ( Chan Jung Park ) 한국컴퓨터교육학회 2009 한국컴퓨터교육학회 학술발표대회논문집 Vol.13 No.2
본 논문은 컴퓨터 프로그래밍 언어가 대학 전공자들에게 조차 어렵게 인식됨에 따라 학습자들의 성공적인 프로그래밍 교육을 위한 동기유발 요인들을 설계, 분석하여 교수-학습 방법 연구에 기여하고자 하였다. 먼저, J 대학교의 컴퓨터 관련학과 전공자들을 대상으로 설문을 통해 프로그래밍에 대한 태도와 동기 요인들을 조사하였다. 이를 바탕으로 요인분석과 회귀분석을 실시한 결과, 학습자들의 프로그래밍에 대한 동기를 유발, 유지하기 위한 중요한 요인들을 찾아낼 수 있었다. 마지막으로, 본 논문에서는 프로그래밍과 관련된 많은 동기요인 중에서도 자아효능감과 흥미가 큰 영향을 미친다는 것을 검증했으며 교수-학습 과정중에 요구되는 사항과 같은 컴퓨터 계열 전공자라 해도 지향하는 바가 다르기 때문에 차별화된 맞춤식 동기유발 전략이 필요함을 제언하였다.
아동기 학대 경험이 노인의 정신건강에 미치는 영향: 노년기 정서적 학대의 매개효과를 중심으로
한지수 ( Ji-su Han ),남일성 ( Il-sung Nam ) 전북대학교 사회과학연구소 2021 지역과 세계 Vol.45 No.2
Depression is an important influencing factor on elderly mental health. Elder abuse and child abuse are risk factors that increase the depression level of the elderly. When an elderly who experienced child abuse is revictimized by experiencing elder abuse, the risk of depression increases even more. Therefore, not only elder abuse but also child abuse draws attention when factors influencing the mental health of the elderly, especially on depression, are identified. This study tries to prove the mediating role of elder abuse between child abuse and depression in old age by showing that child abuse increases elder abuse revictimization and elder abuse has negative influence on elderly depression, and by calculating th indirect effect size of child abuse and elder abuse. The study result shows that child abuse and emotional abuse in old age increase the level of depression respectively and child abuse increase the revictimization risk of the elderly. As the indirect effect of child abuse and elder abuse is statistically significant, the mediating role of elder abuse experience is proved. As possible inventions to decrease depression level, self-help group meeting of the elderly who have experienced both child abuse and elder abuse and life-history telling are suggested to provide positive experiences.